Stage III Bladder Urothelial Carcinoma AJCC v6 and v7

specific

Stage I includes: T1, N0, M0. T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)

74

Centers

137

Active Trials

Cancer Funding

Top Centers for Stage III Bladder Urothelial Carcinoma AJCC v6 and v7(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
Active Research Program
69.5
4
NCI Comprehensive
Active Research Program
69.5
5
NCI Comprehensive
Active Research Program
69.5
6
NCI Comprehensive
Active Research Program
69.5
7
Active Research Program
69.5
8
NCI Clinical
Active Research Program
69.5
9
Active Research Program
69.5
10
Active Research Program
69.5
11
NCI Comprehensive
Active Research Program
54.0
12
NCI Comprehensive
Active Research Program
54.0
13
NCI Comprehensive
Active Research Program
54.0
14
NCI Comprehensive
Active Research Program
54.0
15
NCI Comprehensive
Active Research Program
54.0
16
NCI Comprehensive
Active Research Program
54.0
17
NCI Comprehensive
Active Research Program
54.0
18
NCI Comprehensive
Active Research Program
54.0
19
NCI Comprehensive
Active Research Program
54.0
20
NCI Comprehensive
Active Research Program
54.0
21
NCI Comprehensive
Active Research Program
54.0
22
NCI Comprehensive
Active Research Program
54.0
23
NCI Comprehensive
Active Research Program
54.0
24
NCI Comprehensive
Active Research Program
54.0
25
NCI Comprehensive
Active Research Program
54.0
2654.0
27
NCI Comprehensive
Active Research Program
54.0
28
NCI Comprehensive
Active Research Program
54.0
29
NCI Comprehensive
Active Research Program
54.0
30
NCI Clinical
Active Research Program
54.0
31
NCI Comprehensive
Active Research Program
54.0
32
NCI Comprehensive
Active Research Program
54.0
33
NCI Comprehensive
Active Research Program
54.0
34
NCI Comprehensive
Active Research Program
54.0
35
NCI Clinical
Active Research Program
54.0
36
NCI Comprehensive
Active Research Program
54.0
37
NCI Comprehensive
Active Research Program
54.0
38
Active Research Program
54.0
39
NCI Comprehensive
Active Research Program
54.0
40
NCI Comprehensive
Active Research Program
54.0
41
NCI Comprehensive
Active Research Program
54.0
42
NCI Clinical
Active Research Program
54.0
43
Active Research Program
54.0
44
NCI Comprehensive
Active Research Program
54.0
4554.0
46
Active Research Program
54.0
47
Active Research Program
54.0
48
Active Research Program
54.0
49
Active Research Program
54.0
50
Active Research Program
54.0
51
Active Research Program
54.0
52
Active Research Program
54.0
53
Active Research Program
54.0
54
NCI Comprehensive
Active Research Program
35.2
55
NCI Comprehensive
Active Research Program
35.2
56
NCI Comprehensive
Active Research Program
35.2
57
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
35.2
58
NCI Comprehensive
Active Research Program
35.2
59
NCI Comprehensive
Active Research Program
35.2
60
NCI Clinical
Active Research Program
35.2
61
NCI Comprehensive
Active Research Program
35.2
62
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
35.2
63
NCI Comprehensive
Active Research Program
35.2
64
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
35.2
65
NCI Basic_laboratory
Active Research Program
35.2
66
Active Research Program
35.2
67
Active Research Program
35.2
68
Active Research Program
35.2
69
Active Research Program
35.2
70
Active Research Program
35.2
71
BC CancerVancouver, BC
Active Research Program
35.2
72
Active Research Program
35.2
73
NCI Comprehensive
28.8
74
NCI Comprehensive
28.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →